U07.1 B44.0
Conditions
Interventions
Group 1: The cohort will be retrospectively collected and analyzed after admission to an intensive care unit. Patients with definite CAPA infection will be randomly matched to drawn controls without C
Sponsors
Charité Universitätsmedizin Berlin
Eligibility
Sex/Gender
All
Age
18 Years to 120 Years
Inclusion criteria
Inclusion criteria: severe case of Covid-19
Exclusion criteria
Exclusion criteria: no stay on intensive care unit
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the study is the risk factors for developing CAPA. The cohort will be retrospectively collected and analyzed after admission to an intensive care unit. Patients with definite CAPA infection will be randomly matched to controls without CAPA infection. Clinical and laboratory parameters will be collected and patients will be compared based on these parameters. It is an explorative nested-case-control study. The parameters will be collected from the hospital information system. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dexametason as risk factor für CAPA. | — |
Countries
Germany
Contacts
Public ContactRasmus Leistner
Charité Universitätsmedizin Berlin
Outcome results
None listed